Pinheiro Guimarães and Pinheiro Neto advised on the deal. Brazilian firm Cellera Farmacêutica has acquired the trademark and intellectual property rights of antidepressant drug Pamelor (nortriptyline)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
